HLA-G and glioblastoma: The data suggest that GBM (P=0.0084) patients with high HLA-G expression were significantly more likely to have a shorter disease-free survival (DFS) than patients with GBM with low HLA-G expression (Supporting Information Supplementary Figure 3B).